Cargando…
Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by (1)H NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and Healthy Individuals
[Image: see text] Serologic biomarkers for inflammatory bowel disease (IBD) have yielded variable differentiating ability. Quantitative analysis of a large number of metabolites is a promising method to detect IBD biomarkers. Human subjects with active Crohn’s disease (CD) and active ulcerative coli...
Autores principales: | Schicho, Rudolf, Shaykhutdinov, Rustem, Ngo, Jennifer, Nazyrova, Alsu, Schneider, Christopher, Panaccione, Remo, Kaplan, Gilaad G., Vogel, Hans J., Storr, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2012
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558013/ https://www.ncbi.nlm.nih.gov/pubmed/22574726 http://dx.doi.org/10.1021/pr300139q |
Ejemplares similares
-
Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
por: Kienzl, Melanie, et al.
Publicado: (2020) -
The Argument Against a Biosimilar Switch Policy for Infliximab in Patients with Inflammatory Bowel Disease Living in Alberta
por: Kaplan, Gilaad G, et al.
Publicado: (2020) -
Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell Carcinoma
por: Falegan, Oluyemi S., et al.
Publicado: (2017) -
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
por: Hasenoehrl, Carina, et al.
Publicado: (2017) -
Metabolomic Profiling in Cattle Experimentally Infected with Mycobacterium avium subsp. paratuberculosis
por: De Buck, Jeroen, et al.
Publicado: (2014)